Approval · Notice of Compliance 18543 · 2016
RALIVIA: Notice of Compliance 18543
Issued September 30, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18543
- Date
- September 30, 2016
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RALIVIA | Not yet assigned | — |
Medicinal ingredients
- TRAMADOL HCL 100 MG per TAB
- TRAMADOL HCL 200 MG per TAB
- TRAMADOL HCL 300 MG per TAB